AI
DGX icon

Ariel Investments’s Quest Diagnostics DGX Stock Holding History

Ariel Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-592,375
Closed -$47.6M – 151
2020
Q1 		$47.6M Buy
592,375
+190,909
+48% +$19.8M 0.83% 45
2019
Q4 		$42.9M Sell
401,466
-9,602
-2% -$1M 0.54% 60
2019
Q3 		$44M Buy
411,068
+11,054
+3% +$1.13M 0.59% 60
2019
Q2 		$40.7M Buy
400,014
+6,263
+2% +$602K 0.51% 65
2019
Q1 		$35.4M Buy
393,751
+39,709
+11% +$3.44M 0.44% 69
2018
Q4 		$29.5M Buy
354,042
+93,781
+36% +$8.79M 0.41% 71
2018
Q3 		$28.1M Buy
260,261
+16,662
+7% +$1.83M 0.31% 83
2018
Q2 		$26.8M Buy
243,599
+3,157
+1% +$329K 0.3% 81
2018
Q1 		$24.1M Sell
240,442
-7,690
-3% -$788K 0.28% 83
2017
Q4 		$24.4M Buy
248,132
+114,292
+85% +$10.8M 0.28% 83
2017
Q3 		$12.5M Sell
133,840
-30,317
-18% -$3.22M 0.15% 102
2017
Q2 		$18.2M Sell
164,157
-56,460
-26% -$5.97M 0.22% 89
2017
Q1 		$21.7M Sell
220,617
-151,263
-41% -$14.4M 0.25% 85
2016
Q4 		$34.2M Sell
371,880
-33,104
-8% -$2.85M 0.4% 69
2016
Q3 		$34.3M Sell
404,984
-49,551
-11% -$4.16M 0.41% 69
2016
Q2 		$37M Sell
454,535
-292,559
-39% -$22.3M 0.46% 65
2016
Q1 		$53.4M Buy
747,094
+53,841
+8% +$3.61M 0.64% 56
2015
Q4 		$49.3M Sell
693,253
-2,479
-0.4% -$167K 0.59% 57
2015
Q3 		$42.8M Buy
695,732
+115,177
+20% +$8.05M 0.53% 56
2015
Q2 		$42.1M Buy
580,555
+64,597
+13% +$4.77M 0.47% 60
2015
Q1 		$39.7M Buy
515,958
+129,450
+33% +$9.27M 0.44% 59
2014
Q4 		$25.9M Buy
386,508
+37,598
+11% +$2.37M 0.3% 74
2014
Q3 		$21.2M Sell
348,910
-4,018
-1% -$248K 0.27% 78
2014
Q2 		$20.7M Buy
352,928
+57,769
+20% +$3.38M 0.25% 80
2014
Q1 		$17.1M Buy
295,159
+27,106
+10% +$1.45M 0.21% 85
2013
Q4 		$14.4M Buy
268,053
+219,114
+448% +$13M 0.18% 94
2013
Q3 		$3.02M Buy
48,939
+41,494
+557% +$2.48M 0.04% 129
2013
Q2 		$451K Buy
+7,445
New +$444K 0.01% 133

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ariel Investments's DGX Position: Q2 2020 in Review

Ariel Investments sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 592,375 shares — an estimated $47.6M sold.

Ariel Investments first reported a position in DGX in Q2 2013 and held it in 28 quarters. The position peaked at $53.4M in Q1 2016. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • Ariel Investments reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Ariel Investments sold 592,375 Quest Diagnostics shares in Q2 2020, an estimated $47.6M.
  • Ariel Investments first reported a position in Quest Diagnostics in Q2 2013 and held it in 28 quarters.
  • Ariel Investments's Quest Diagnostics position peaked at $53.4M in Q1 2016.
  • 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Ariel Investments's 13F filing for Q2 2020, filed 14 Aug 2020.